The current first-line treatment for leishmaniasis, a skin disease that can cause disfiguring ulcers, is grueling and frequently fails. A new study pinpoints genetic factors that predict whether a patient will respond well to treatment. The work could inform the creation of prognostic tests that could help clinicians personalize therapies for individual patients.
Related Posts
Order Antibiotics online
June 8, 2024Buying antibiotics online
June 8, 2024How do antibiotics work?
June 8, 2024Flagyl: a beacon of hope in the fight against trichomoniasis
February 17, 2024Metronidazole for bacterial infection
February 1, 2023